Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of Internal Medicine
Despite the scale of prostate-specific antigen (PSA) testing for prostate cancer screening, prediction models do not predict time-to-event end points or adjust for patient life expectancy.
Family Medicine/General Practice February 6th 2026
MedCentral
“The pain may not correlate with the extent of the disease. A patient with severe endometriosis may report little pain while someone with little extent of disease may report much pain.”
Obstetrics & Gynecology January 13th 2026
Cancer Therapy Advisor
Although men in this cohort have a good prognosis, this finding is clinically relevant, as change in PSA is a factor in determining whether men opt to remain on [active surveillance].
Geriatrics November 17th 2025
Cleveland Clinic | Consult QD
“Controlling cancer is, of course, the goal, but there must also be a greater emphasis on life after treatment.”
Obstetrics & Gynecology September 15th 2025
Journal of Physician Assistant Education (JPAE)
Survey findings demonstrate that clinical supervisors often send students away before opposite-gender patients enter, believing patients would be uncomfortable, without actually asking for patient consent.
Family Medicine/General Practice July 18th 2025
Fox Chase Cancer Center
Statistical models incorporating individual clinical and tumor characteristics showed superior accuracy when validated against standardized clinical trial data compared to retrospective prediction tools.
Oncology, Medical June 24th 2025